Literature DB >> 25070042

Pituitary side effects of old and new drugs.

Maria Chiara Zatelli1, Maria Rosaria Ambrosio, Marta Bondanelli, Ettore Degli Uberti.   

Abstract

INTRODUCTION: Pituitary function is influenced by several drugs, including anti-depressant, opioids, glucocorticoids, chemotherapeutic agents, immunomodulators and the newly developed tyrosine kinase inhibitors. In most instances, treatment with these drugs negatively affects pituitary function, but in rare cases an activation of specific hypothalamic-pituitary axes may be observed. Several of the observed pituitary side effects are reversible after drug withdrawal, but pituitary function deficiency may persist long-term. In addition to the well known drugs, recent evidence shows that also non-steroidal anti-inflammatory drugs impair gonadal axis at pituitary level, while antipsychotic phenothiazines alter TSH response to TRH and TSH levels. Atypical antipsychotics may decrease TRH-stimulated TSH. Tricyclic antidepressant drugs interfere with the hypothalamo-pituitary-thyroid axis by decreasing TSH response to TRH. Anabolic-androgenic steroids, marijuana, cocaine, methamphetamines, and opioid narcotics negatively impact fertility, also acting at hypothalamic-pituitary level.
CONCLUSIONS: Many of the drugs administered routinely in the intensive care unit significantly impact the hypothalamic-pituitary axis. Therefore, an increased awareness on pituitary side effects of drugs commonly used in clinical practice is necessary in order to rule out possible pharmacological interference when assessing patients with pituitary deficiencies.

Entities:  

Mesh:

Year:  2014        PMID: 25070042     DOI: 10.1007/s40618-014-0133-2

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  77 in total

1.  Reduction in basal afternoon plasma ACTH during early treatment of depression with fluoxetine.

Authors:  W J Inder; T C Prickett; R T Mulder; R A Donald; P R Joyce
Journal:  Psychopharmacology (Berl)       Date:  2001-06       Impact factor: 4.530

Review 2.  Treating depression with selective serotonin reuptake inhibitors: a practical approach.

Authors:  S M Sampson
Journal:  Mayo Clin Proc       Date:  2001-07       Impact factor: 7.616

Review 3.  Management of adrenal cancer: a 2013 update.

Authors:  M Terzolo; F Daffara; A Ardito; B Zaggia; V Basile; L Ferrari; A Berruti
Journal:  J Endocrinol Invest       Date:  2014-03       Impact factor: 4.256

4.  EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas.

Authors:  Hidenori Fukuoka; Odelia Cooper; Anat Ben-Shlomo; Adam Mamelak; Song-Guang Ren; Dave Bruyette; Shlomo Melmed
Journal:  J Clin Invest       Date:  2011-11-21       Impact factor: 14.808

5.  Brain benzodiazepine receptor-mediated effects on plasma catecholamine and corticosterone concentrations in rats.

Authors:  S F De Boer; J Van der Gugten; J L Slangen
Journal:  Brain Res Bull       Date:  1990-06       Impact factor: 4.077

6.  Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy.

Authors:  Lucile Capuron; Charles L Raison; Dominique L Musselman; David H Lawson; Charles B Nemeroff; Andrew H Miller
Journal:  Am J Psychiatry       Date:  2003-07       Impact factor: 18.112

7.  Effects of non-steroidal anti-inflammatory drugs on hormones and genes of the hypothalamic-pituitary-gonad axis, and reproduction of zebrafish.

Authors:  Kyunghee Ji; Xiaoshan Liu; Saeram Lee; Sungeun Kang; Younglim Kho; John P Giesy; Kyungho Choi
Journal:  J Hazard Mater       Date:  2013-03-22       Impact factor: 10.588

8.  Inappropriate elevation of serum thyrotropin levels in patients treated with axitinib.

Authors:  Kenji Ohba; Tatsuya Takayama; Hideyuki Matsunaga; Akio Matsushita; Shigekazu Sasaki; Yutaka Oki; Seiichiro Ozono; Hirotoshi Nakamura
Journal:  Thyroid       Date:  2013-04       Impact factor: 6.568

9.  Acute administration of alprazolam, a benzodiazepine activating GABA receptors, inhibits cortisol secretion in patients with subclinical but not overt Cushing's syndrome.

Authors:  Roberta Giordano; Rita Berardelli; Ioannis Karamouzis; Valentina D'Angelo; Andreea Picu; Clizia Zichi; Beatrice Fussotto; Maria Manzo; Giulio Mengozzi; Ezio Ghigo; Emanuela Arvat
Journal:  Pituitary       Date:  2013-09       Impact factor: 4.107

10.  Dose-response characteristics of neonatal exposure to genistein on pituitary responsiveness to gonadotropin releasing hormone and volume of the sexually dimorphic nucleus of the preoptic area (SDN-POA) in postpubertal castrated female rats.

Authors:  K A Faber; C L Hughes
Journal:  Reprod Toxicol       Date:  1993       Impact factor: 3.143

View more
  2 in total

1.  Activation of the vitamin D receptor transcription factor stimulates the growth of definitive erythroid progenitors.

Authors:  Jeffrey Barminko; Brad M Reinholt; Alexander Emmanuelli; Alannah N Lejeune; Margaret H Baron
Journal:  Blood Adv       Date:  2018-06-12

Review 2.  Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task.

Authors:  Agnese Barnabei; Lidia Strigari; Andrea Corsello; Rosa Maria Paragliola; Giovanni Maria Iannantuono; Roberto Salvatori; Salvatore Maria Corsello; Francesco Torino
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-21       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.